PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS

CONTEXT: Atypical antipsychotics (AAs) are the first-line treatments for schizophrenia, schizoaffective disorder and bipolar disorder. However, they are now extensively utilized as off label in a myriad of diseases despite their frequently serious metabolic side-effects and hyperprolactinemia. OBJEC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Endocrinol (Buchar)
Autors principals: Matei, V.P., Purnichi, T., Mihailescu, A., Grigoras, R.
Format: Artigo
Idioma:Inglês
Publicat: Acta Endocrinologica Foundation 2018
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516404/
https://ncbi.nlm.nih.gov/pubmed/31149301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.483
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars